Pulmonary Complications
Part 1
Patrick
Herlihy, MD
Part 1
Part 2
Part 3
Introduction
Cardiac surgery has significant and well studied
effects on pulmonary physiology. A major impact
of surgery is to decrease pulmonary compliance (Cp)
(1,2,3). Causes for the decreased Cp include increased pulmonary
capillary volume and extravascular lung water as a consequence of the
crystalloid solution patients receive in the course of cardiopulmonary bypass (CPB), as
well as microatelectasis which is multifactorial in etiology
(1). Atelectasis is caused, in part, by anesthetic and neuromuscular blockade (paralysis), which
typically cause cephalad shift of the diaphragm in supine patients. This
decreases functional residual capacity (FRC) below the lungs' closing
volume (4). The lungs are also typically deflated to some degree during cardiac surgery
to allow clear access to the to the heart, even if
the procedure is done off CPB and through new "minimal
access" techniques. This, as well, contributes to atelectasis. Chest wall compliance, by
view of recent studies (5), is also decreased after sternotomy,
though minimally and for only a brief (<4
hours) period. Airway resistance (AR) is generally increased after
cardiac surgery (2) for unclear reasons, but possibly because of
bronchial edema.
The clinical effects of these physiologic changes are primarily two.
Ventilation/perfusion (V/Q) relationships are altered creating physiologic
shunting through poorly ventilated lung units resulting in an increased
alveolar-arterial oxygen difference (A-a O2D). Though this effect can be
very different between patients, it is on average about 70 mm Hg. To
prevent hypoxemia, therefore, post cardiac surgery patients require,
typically, increased fraction of inspired O2 (FiO2). It is noteworthy that
this effect is seen in patients whose surgery is performed off CPB,
through minimal access approaches, in addition to patients receiving
traditional treatment (6). This effect can last only hours or for a few
days, depending upon the patient. The other effect of physiologic changes
post surgery is that patients experience increased work of breathing (WOB)
consequent to the increased AR, and decreased Cp. For the vast majority of
heart surgery patients this is inconsequential to their clinical course.
However, in patients with significant underlying neuromuscular disease or
pulmonary pathology, especially those with chronic obstructive lung
disease (COPD), these changes may prove troublesome and result in
prolonged mechanical ventilation (MV).
Incidence of pulmonary complications
There are
many potential pulmonary complications of cardiac surgery. They
will be individually discussed in detail through the other sections
of this chapter. However, it is helpful to know the general
incidence of the more common and morbid problems.
Prolonged MV (>48 hours), is required in from 10 - 23% of post
cardiac surgery patients (7,8). o Atelectasis of a great enough extent to
be present on chest X - ray (CXR), is common post cardiac surgery. One
recent study reported an incidence of left lung atelectasis at 88%, and
right lung Atelectasis at 61% (9).
Pulmonary edema, to greater or lesser degrees, typically is present in
patients post CPB (10).
Diaphragm dysfunction, not necessarily effecting clinical outcome, but
when looked for aggressively with sophisticated techniques, is present in
25% to 50% of post cardiac surgery patients (11).
Pleural effusions are common after cardiac surgery, occurring in 40% to
90% of patients depending upon the series (12,13). Most effusions are
small in size, however, and do not require treatment. Large effusions
(>25% of the hemithorax) occur in slightly less than 1% of cardiac
surgery patients (14).
The Adult Respiratory Distress Syndrome (ARDS) occurs in 1% to 2% of
post cardiac surgery cases but is associated with significant mortality
(15). o Pneumonia occurs in 4 - 6% of cardiac surgery patients (16,17).
Pulmonary embolism (PE) is thought to be rare after cardiac surgery,
but in a recent large series it complicated 3% of the cases (18). When PE
occurs post cardiac surgery, it is associated with a mortality of 18% to
34% (18,19).
Pulmonary arterial hypertension is common after cardiac surgery, but is
only unusually associated with notable clinical problems. However,
patients with severe biventricular failure and those undergoing congenital
heart surgery, mitral valve replacement, orthotopic heart transplant, and
left ventricular assist device placement are at particular risk for the
development of severe pulmonary hypertension which can lead to right
ventricular decompensation and, rarely, mortality (20).
Preoperative evaluation
The risk factors for pulmonary complications following cardiac surgery
can be divided into specific pulmonary pathologies, usually present long before
the need for surgery, and other "nonpulmonary" conditions, which can result in prolonged MV.
The following are the major lung conditions, listed in order of
importance, that can dispose the post heart surgery patient
to even greater than expected impairment of oxygenation, prolonged MV, atelectasis,
and pulmonary infections (4,21):
- COPD characterized by (FEV- 1) of <1.5 L or FEV - 1/Forced vital capacity (FVC) ratio of <65%.
- Asthma, poorly controlled.
- Active pulmonary infections
- Restrictive lung diseases such as idiopathic pulmonary fibrosis
(IPF).
- Smoking history of generally greater than 20 pack years.
- Obesity
One early study (22) reported a
postoperative incidence of pulmonary complications in patients with abnormal preoperative
PFTs to be 42%. With optimization of pulmonary function in these
"at risk" patients before and after surgery, usually by
treating COPD with bronchodilators and pulmonary secretion management techniques, the complication
rate was cut by two thirds. More recent studies have not
shown such dramatic improvement in complication rates of "at risk" patients by aggressive, targeted
perioperative care (23). It appears, though, that these patients are now
routinely receiving some pre and postoperative pulmonary therapy, due
to increased awareness of pulmonary complications, making it difficult to demonstrate
major improvements in studies.
We recommend,
therefore, screening patients for these risk factors, and
optimizing the pulmonary status of patients who have them pre and
post surgery. In addition to the risk factors identified above, we also
recommend for pulmonary evaluation those patients with dyspnea
out of proportion to their cardiac pathology. The evaluation should include,
at least, PFTs and a plain chest radiograph. There
are no PFTs which are absolutely prohibitive for cardiac surgery (24). The
choice of whether or not patients with lung disease have cardiac surgery is an
individual one which entails measuring the risks versus benefits for the
individual patient.
Therapy for patients with COPD includes pre and postoperative inhaled
bronchodilators (see Drug Table 1 at the end of the chapter) routinely. If
the patient has had a recent exacerbation of COPD, we will often treat
with a short course of steroids preoperatively to optimize lung function.
Chronic bronchitis will require special attention to pulmonary secretion
clearance postoperatively. This includes aggressive endotracheal
suctioning of patients on MV in the recovery room (RR), for the immediate
postoperative period. A closed suctioning system that attaches to the
endotracheal tube (ETT) is more convenient for the nursing and respiratory
therapy staff and often, therefore, results in more frequent suctioning.
However, if secretions are thick and difficult to remove, traditional
"open" (patient disconnected from the ventilator) ETT suctioning with
sterile saline and bagging is more effective. Mucolytics are often
employed in either inhaled form (acetylcysteine) or enterally (guifenesin)
(see Drug Table 3 at the end of the chapter). It should be born in mind
that inhaled acetylcysteine can sometime provoke bronchospasm. If asthma
is not optimally controlled preoperatively with the usual chronic agents
we will treat with a short course of steroids. Pulmonary infections should
be treated with appropriate antibiotics preoperatively, and completely
cleared before proceeding to surgery Patients with interstitial lung
disease can be expected to require higher levels of FiO2 for longer
periods of time post operatively. This group of patients is certainly at
greater risk of developing additional pulmonary complications, but is at
notably less risk than patients with obstructive lung disease (24).
Smokers should stop tobacco use prior to surgery. Extrapolating from the
general surgery literature, patients should be smoke free for at least six
weeks prior to surgery for maximal benefit (25).
Obesity has traditionally been considered a major risk factor for
pulmonary complications after cardiac surgery. Although obesity clearly
increases the A-a O2D post cardiac surgery to a mild or moderate degree
(26), and slightly increases the risk of postoperative PE (18), recent
large series have failed to confirm it's association with other major
pulmonary complications such as prolonged mechanical ventilation (27,28).
Therefore obese patients should be encouraged to lose weight prior to
cardiac surgery, but it does not appear to be critical in preventing
postoperative pulmonary complications. Typically all patients going for
cardiac surgery are taught, before surgery, the benefits and techniques of
coughing and deep breathing post operatively. This involves demonstrating
the use of pillows specifically made for sternotomy patients to brace the
surgical site in the several days post operatively, as well as the use of
the incentive spirometer, which we recommend hourly in our typical post
operative patients.
Nonpulmonary conditions associated with prolonged MV after
cardiac surgery according to recent large clinical series (29,30), include
(with relative odds ratios):
- Age >65 years (1.31).
- Inpatient hospitalization before surgery (1.39)
- Peripheral vascular disease (1.26)
- Cardiogenic shock (2.54) or severe left ventricular dysfunction
(1.27)
- Renal insufficiency (1.27) o Serum albumin of <4.0 g/L (1.24)
- Systemic oxygen delivery of <320 mL/min/m2 (1.27)
- A "redo"operation, reexploration of the chest for bleeding, or
delayed sternal closure (1.47) o procedures involving the thoracic aorta
(1.92)
- transfusion of greater than 10 units of blood products (1.87)
- CPB time of greater than 120 minutes (1.23)
These conditions promote prolonged MV through a variety of mechanisms
and do not generally lend themselves to preoperative remediation. It is
helpful, however, to understand their impact on the post CS pulmonary
course.
Mechanical ventilator supoort
Following cardiac surgery patients are taken off CPB and sent back to the
RR on a mechanical ventilator. Uncomplicated patients will require
mechanical ventilatory support typically for some hours until they are
ready to "wean" from the ventilator and have their ETT tube removed.
During this time the patient recovers from hypothermia, anesthesia,
neuromuscular blockade, and typically regains hemodynamic stability. The
ventilator for this period is set in a "support mode", that is a mode,
which essentially does all of the WOB for the patient. The two commonly
used support modes are assist control (AC) and synchronized intermittent
mandatory ventilation (SIMV) with pressure support (PS). These are "volume
cycled ventilator modes". In each of these modes a respiratory rate and
tidal volume is set for the ventilator. For example, a typical respiratory
rate (RR) would be 10 and tidal volume (Vt) 800 mL. In both of these modes
the patient will, at least 10 times a minute, get a Vt of 800 mL. In
either mode, patients can initiate breaths between the preset Vts. In both
modes the ventilator will augment those breaths, but in different ways. In
AC, when the ventilator senses that the patient is initiating a breath, it
will give the patient the preset Vt. For example, if our patient on AC set
at a RR of 10 with a Vt of 800 mL initiates 5 extra breaths a minute, each
of those breaths will be 800 mL. The patient's total minute ventilation
(Ve) will be 15 breaths x 0.8 L = 12 L. In the SIMV mode with PS, a PS
level is selected in addition to a RR and Vt. When the patient initiates a
breath between the preset Vts, the ventilator will generate air flow
through it's inspiratory loop. The amount of airflow will be enough to
maintain a positive airway pressure, at the selected PS level, while the
patient is actively inspiring. The purpose of PS is to aid the patient in
breathing through the ventilator tubing and circuitry. The size of the Vt
that the patient actually receives depends upon how strongly he or she
inspires, the level of pressure support, and the length of time that he or
she inspires. For example, if our patient is placed on SIMV at a RR of 8
with a Vt of 800 mL and PS of 15 cm H2O, Ve will be at least 8 x 0.8 L =
0.64 L. If, however, he initiates 5 extra breathes per minute which are
pressure supported to a Vt of, on average, 0.5 L, his Ve will be 5 x 0.5 L
=
0.25L added to the 0.64
L for a total Ve of 0.89 L.
There are no studies to show which of these two
volume-cycled-ventilator modes are superior in supporting patients post CS
or supporting patients with respiratory failure in general. It is very
important, however, that when the SIMV mode is used that it be used in
conjunction with pressure support. Pressure support compensates for the
work of breathing through ventilator circuitry. Without PS, the work of
breathing through the ventilator can be fatiguing for patients'
respiratory muscles, and actually prolong the need for MV (31). Typical
settings for using the either the AC or SIMV ventilator modes are: o RR: 8
- 12 breaths per minute o Vt: 10 - l5 mL per kg o PS: 5 - 15 cm H2O (our
institution routinely uses 10 in our post cardiac surgery patients) These
settings were developed from anesthesia experience to prevent both over
distention of the lung resulting in "barotrauma" and under distention of
the lungs resulting in atelectasis. These settings, additionally, will
generally result in eucapnia, but it's appropriate and routine practice to
check arterial blood gasses approximately 20 minutes after arriving in the
recovery room. When patients arrive in the RR the FiO2 delivered by the
ventilator is typically 0.60 or 60%, as long as the oxygen carrying
capacity of the blood is not compromised by an O2 saturation of less than
90%. FiO2 above 0.60 is generally considered to be toxic to the lungs
through generation of oxygen radicals.
Ventilators in common use typically offer several
options for the inspiratory flow pattern and allow peak inspiratory flow
rate to be set. The "decelerating ramp" flow pattern is generally
considered to deliver gas in the most physiologic way and is usually
preferred. Peak inspiratory flow rates are generally initially set at 60
L/min but may be varied up and down substantially depending upon the needs
of the patient. The latest generation of ventilators, utilizing
sophisticated computer programs, will calculate the AR and Cp of the
patient's lung, on a breath-to-breath basis, and deliver Vts through a
flow rate and pattern that is most physiologically appropriate. Positive
end expiratory pressure (PEEP) use, as a standard post cardiac surgery,
varies from institution to institution. Argument for using a low level of
PEEP routinely in post cardiac patients is that it helps prevent
microatelectasis. "Physiologic PEEP" is usually set at about 5 cm H2O.
Argument against its routine use is that it can negatively impact
hemodynamics by increasing intrathoracic pressure, thereby decreasing
venous return to the right heart as well as increasing right ventricular
afterload. Again, no data exists as to whether routine use of PEEP in post
CS patients is beneficial or not. At our institution, because of concern
for hemodynamics we do not routinely use PEEP.
Ventilator trouble shooting
The ventilator is adjusted in the early postoperative
period based on arterial blood gas (ABG) sampling and "peak inspiratory pressure" (PIP). In general, the
partial pressure of arterial CO2 (paCO2) is targeted to be 35
- 45 mm Hg, which, unless there is a concurrent metabolic acid
base disturbance, should result in an acceptable pH of 7.35 - 7.45.
paCO2 is directly proportional to the alveolar ventilation (Va) which is equal
to the Ve minus the dead space ventilation (Vd) (that portion of
the lung which ventilated but not perfused such as the airways).
Ve is equal to the RR x the Vt. In normal
lungs about 150 mL. of each Vt is Vd. Va
is, therefore, equal to the RR x (Vt - 0.15).
So to
treat respiratory acidosis or alkalosis that has developed on the
ventilator the Va is adjusted up or down in proportion to
the amount of change in the CO2 required to achieve
eucapnea. This can be done by adjusting the Vt or the
RR, which is usually preferred. Suppose for example, if we have a patient
with a paCO2 of 50 and a pH of 7.32 immediately post
operatively on MV settings of AC, RR 8, and Vt of 800
mL who is not initiating any breaths. The Va is equal
to 8 x (0.8 - 0.15) =
5.2 L. To bring the pCO2 down 20%
to 40 mm Hg, the Va needs to be increased
20% to about 6.24 L. By increasing the RR to
10 the Va will increase to 6.5 L, approximately the Va
needed. Partial pressure of arterial oxygen (PaO2) is targeted to be
greater than 60 mm Hg (correlating to an arterial oxygen saturation greater
than 90%) hopefully using a FiO2 of 60% or
less.
Ventilator strategies to improve oxygenation are discussed in the
section on hyperemia. It is important to pay attention to PIPs.
Ventilators measure pressures in the ventilator circuitry as a way to
estimate the patients' airway pressures. PIP is the peak positive pressure
detected while the patient is receiving a breath from the ventilator.
Elevated PIP (>35 cm H2O) signifies pulmonary pathology or
patient-ventilator malinteraction. High PIPs are caused by either an
increase in AR, a decrease in Cp, or extra pulmonary parenchymal
pathologies causing increased pleural pressure which is then transmitted
to the airways. When the PIP is elevated the first question is if it is
due to increased AR. Some ventilators will calculate and display AR on a
breath by breath basis. Values above 4 cm/L/second are elevated.
Otherwise, a quick maneuver to assess AR is to have the ventilator hold
the Vt in the patient for 1 - 2 seconds. This is usually done through the
"inspiratory pause" function of the ventilator. At the end of the pause
the ventilator will read out a "plateau pressure" (PP). This pressure
should roughly reflect the alveolar pressure, as there is no airflow
between the ventilator pressure transducer and the alveoli during an
inspiratory pause. If the PP is low, and the PIP is high, the problem is
one of AR. If the PP is high, as well as the PIP, the problem is one of
poor Cp or increased pleural pressure. Causes of increased AR include:
- Malposition of the ETT.
- Bronchospasm and/or airway edema
- Biting of the ETT
The ETT can be too high with the tip being in the
larynx. The ETT tube can be too low, either up against the carina or in
one of the main stem bronchi. Occasionally the ETT can be up against the
tracheal wall in patients with airway, abnormalities from, for example,
kyphoscoliosis, or a prior extensive lung injury resulting in a torturous
trachea. Mucus or mucopurulent plugging of the ETT tube or airway.
Assessment for these
possibilities should include physical examination with inspection of the
ETT tube where it exits the mouth. Look for biting of the tube and tube
position. In general the ETT should be approximately 21 cm at the teeth
for an average size woman and 23 cm for an average size man. Ausculation
should be performed for rhonchi suggesting airway secretions and wheezing
suggesting bronchospasm. Focally decreased breath sounds can signify
bronchial obstruction by mucous plugging, as well as pneumothorax and
pleural effusion. CXR examination after cardiac surgery is routine and
should be checked for the position of the ETT (3 cm. +/- 1 cm from the
carina). If, after inspection, auscultation, and review of the CXR the
cause of AR is not obvious, a suction catheter should be introduced
through the ETT to feel for resistance and to suction possible mucous
plugs. If resistance is met, the ETT should be repositioned if poor
positioning appears to be the problem. If ETT positioning is not the
problem, and the patient has relatively stable gas exchange, then a
bronchoscope should be performed through the ETT to inspect the etiology
of the airway obstruction. The bronchoscope can sometimes more efficiently
clear secretions and guide the position adjustment of the ETT. There are
occasions when the airway is obstructed and gas exchange rapidly
deteriorates into a dangerous range. In these circumstances it is most
appropriate to emergently extubate and reintubate the patient. This should
be done by an anesthesiologist or a pulmonologist experienced in difficult
airway management.
If PIP elevation is not caused by AR then the problem
is pathology causing poor Cp or increased pleural pressure. PP is elevated
in both of these circumstances and Cp (static) is decreased. Many modern
ventilators will calculate the static Cp, but you can calculate it
yourself through the following formula: Cp = Vt / PP - PEEP. Cp less than
50 mL./cm H2O indicates a problem. Lung parenchymal problems causing
significantly decreased Cp include any air space filling or interstitial
infiltrative processes.
In the post cardiac surgery population the most
common cause is pulmonary edema from congestive heart failure and/or
volume over load. Nonhydrostatic pulmonary edema (adult respiratory
distress syndrome) and diffuse, severe pneumonia can markedly decrease
lung compliance as well. Increased pleural pressure can be created by
chest wall edema, abdominal distention, pneumothorax, pleural effusions,
patient ventilator malinteraction, or "intrinsic PEEP". Intrinsic peep
(Pi) is a pathophysiology that can occur in patients with obstructive lung
disease which can create markedly elevated PPs (32). In this disorder,
because of expiratory flow limitation, air is trapped in the lung,
creating large increases in pleural pressure. Evaluation for these
possibilities should begin with inspection to look for signs of patient
ventilator malinteraction such as patient inspiratory or expiratory
efforts out of synchrony with the ventilator cycle. The chest wall and
abdomen should be inspected as well. Auscultation for crackles, signifying
interstitial or air space filling processes and for decreased focal breath
sounds consistent with pneumothorax or pleural fluid should be performed.
Again, the postoperative CXR will be an important diagnostic tool to look
for these pathologies. To diagnose Pi the ventilator's expiratory port is
occluded at the end of expiration, if positive pressure is detected Pi is
present. Many recent vintage ventilators have automated programs to do
this. Treatment of specific entities causing elevated PP and depressed Cp
will be discussed below. However, while specific underlying pathologies
are being treated it is very important to adjust the ventilator to
decrease the PIP (ideally to less than 35 cm H2O) and especially the PP
(to less than 30 cm H2O).
Remember the PP reflects the pressure seen by
the alveoli. High pressures in the alveoli can cause them to rupture
creating a pneumothorax or pneumomediastinum, and are also associated with
overdistension of these lung units and consequent injury (sometimes called
"volutrauma") (33). The first therapeutic maneuver is to decrease the Vt.
If the pressures are still elevated, then, depending upon the ventilator,
the peak inspiratory flow rate should be decreased or the inspiratory time
increased. Maneuvers thereafter are dependent upon the specific causative
problem
Problems with weaning and extubation
Patients are ready to wean when the
following conditions are met:
- Anesthesia and neuromuscular blockade have abated and neurologic status is adequate.
- Gas exchange is adequate.
- Hemodynamics are stable.
- There is no evidence of active post-operative
bleeding.
At our institution, non-complicated cases are weaned per
respiratory therapist driven protocol. To initiate the protocol, the
patient must be alert, following commands and able to raise his or her
head up off of the bed without assistance. "Pulmonary mechanics" are also
performed to grossly assess neuromuscular function. These are a series of
maneuvers done by the respiratory therapist to assess the ventilatory
muscle power. At our institution we use two, the maximum inspiratory force
(MIF), which is the maximum negative inspiratory pressure that the patient
is able to generate, and the vital capacity (VC), which is the maximum
amount of volume a patient can expire after taking in as deep a breath as
possible. Prior to extubation, we would like to see our patients generate
a MIF of greater than or equal to 20 cm. and a VC of >10 mL/kg.
Adequate gas exchange is demonstrated by a PaO2 of >60 on an FiO2 of
<60%.
When patients are extubated and removed from positive pressure
ventilation, typically their ventilation-perfusion matching worsens
slightly, and FiO2 requirement goes up by approximately 10 - 20%.
Therefore, as a general rule, we do not extubate patients from higher FiO2
as it could place them at risk for hypoxemia. PaCO2 in general should be
<45 to extubate. In patients, however, with advanced COPD, the CO2 is
allowed to be near their baseline. Mean arterial pressure (MAP) should be
>60 and stable, as organ function below this MAP is compromised,
including heart, brain, renal and diaphragm function. Weaning compromises,
in essence, transferring WOB from the ventilator to the patient. There are
several ways to do this. At our institution, the SIMV rate is gradually
turned down and eventually off, and the patient is placed on only PS. PS
of from 8 - 14 cm, is enough to compensate for the WOB through the
ventilator circuitry in patients with various types of lung diseases (34).
Because of the increased AR and decreased Cp seen routinely in post CS
patients (see above section Alterations of pulmonary physiology following
cardiac surgery), we place our patients on a PS level of 10 cm. The
patient is then followed on PS from 30 minutes to two hours after which
ABG is checked for hypoxemia or hypercarbia. Just as importantly, though,
the rapid shallow breathing index (RSBI) is calculated. This is a
parameter developed to predict success of extubation (35). The RSBI is
calculated by the equation: Vt (liters)/RR (breaths per minute). If this
ratio is <105, then the patient should be successfully extubated. Prior
to actual extubation, patients at our institution are first taught proper
coughing technique for when the ETT is removed. This entails use of a
specially designed pillow to brace against their sternum when coughing.
Then, typically, our respiratory therapists or nurses will suction the
patient's mouth and hypopharyngeal areas where secretions sometimes will
pool, as well as suction the airways through the ETT. The ETT is removed
while the patient is forcefully expiring. An oxygen mask delivering a FiO2
of about 10% higher than that used for MV is placed on the patient. The
FiO2 is then gradually dropped to the lowest level that still maintains
adequate oxygen saturation over the ensuing minutes to hours. For at least
several hours after extubation, we encourage frequent coughing and
incentive spirometry use.
It is important to be aware that a small
percentage of patients will exhibit signs of laryngeal edema after
extubation. The edema is caused by ETT trauma to the upper airway.
Patients at risk for this development include those whose intubation was
difficult, and those who have experienced prolonged MV. Signs of edema may
not be immediately obvious, but may be delayed for one to two hours
Clinically, the patient will exhibit signs of respiratory distress with
increased respiratory rate, use of accessory breathing muscles. Hoarseness
often accompanies this symptomatology and on physical examination, stridor
can be appreciated. Treatment is nebulized racemic epinephrine and
glucocorticoids (methylprednisolone or decadron) (see Drug Table 2 at end
of chapter). At our institution, we have had some success with the use of
a helium oxygen mixture, which allows easier flows through the edematous
airway. However, reintubation should be performed if the patient does not
exhibit improvement rather quickly, as delay may so compromise the airway,
that an ET tube will be unable to be pass through the glottis. If this
occurs, an emergent tracheostomy will be required.
Prolonged ventilatory management
The majority of cardiac surgery patients are weaned off the ventilator in less
than 48 hours. Between 10 and 23% of patients, however, are not. These
patients have persistent neurological, pulmonary, cardiac or ventilatory
mechanics problems, which require continued MV. The question arises in
this circumstance of what is the best ventilator strategy to support these
patients until they are ready to be weaned off MV. There is actually very
little guidance from clinical studies to answer this question. However, in
addition to providing adequate oxygenation and ventilation, two concerns
typically inform most recommendations. These are concern for the
development of diaphragm and other ventilatory muscle deconditioning, and
contrarily, concern that patients may be forced to perform too much WOB.
Animal data suggests that the diaphragm and other ventilatory muscles can
certainly become deconditioned within a matter of days (36). Therefore, it
is best to allow patients some WOB. Recently, an entity called "iatrogenic
ventilatory dependence" has become a concern (37). This occurs when the MV
is set in such a way that the patient has a constantly fatiguing load to
breathe against. Our institutional approach is usually to use the SIMV
mode with PS. RR is set at 8 -12, with a standard Vt (10 - 15 mL/kg). PS
is generally set at from 10 - 20 cm H20 so that the patient initiated
breath will be at least 5 mL/kg or 500 cc. The overall respiratory rate,
meaning both the SIMV rate and the patient initiated respiratory rate,
should be approximately 15 - 25 breaths/minute. This generally will allow
the patient an adequate amount of work, but not too much. Often, we will
increase the SIMV rate at night to allow the patient rest. So, for
example, if we have a patient who has had a post-operative stroke, and
whose mental status does not allow rapid weaning from the mechanical
ventilator, we will set the SIMV rate at 4 and pressure support at 15 cm
during the day, and an SIMV rate of 8 and pressure support of 15 cm at
night.
If it appears that the patient will require mechanical ventilation
for more than ten days or so, we recommend tracheostomy. This practice is
in concordance with recent societal and expert recommendations for
tracheostomy in patients who will require prolonged MV (38). The reasons
for these recommendations include:
- Glottic protection.
- Patient comfort and the ability to do mouth care.
- A more secure airway.
- Greater ease of weaning from the mechanical ventilator.
There has been some debate in
the post CS patients as to where the tracheostomy should be placed. There
has been an argument made that the tracheostomy should be a
cricothyroidotomy as this incision location is further from the sternotomy
wound and may result in less sternal wound infection (39). At our
institution, however, we perform tracheostomy in the standard position as
we have found this to result in far less difficulties with the airway.
Percutaneous tracheostomy is often performed at our institution, but for
patients with a thick neck or for other anatomic concerns, a standard
tracheotomy is preferred. Most often both procedures can be done at the
bedside.
Occasionally, patients will come out of cardiac
surgery with an open chest. This can be either an open sternum with skin
closure or a completely open chest with dressing. The reason for this is
usually substantial mediastinal bleed at the time of operation, or cardiac
edema. These patients require full mechanical ventilatory support and, in
fact, also deep sedation, if not neuromuscular blockade, so that the
mediastinum is not further traumatized by the sternotomy edges.
Patients
who will require prolonged mechanical ventilation (clearly for more than
48-hours) should be started on nutrition. Enteral feeding is preferred and
is best be instituted with the placement of a soft, distally weighted
feeding tube, placed through the nose. These tubes are designed to be
floated through the stomach and to have their distal tip in the duodenum.
Such tubes decrease the patient's risk of lung aspiration of feeds. High
nutritional tube feeding formulas are typically started at a low rate of
10-20 mL/hour which is advanced over the next 24 hours to a target rate
which provides the estimated caloric and protein needs of the patient. We
often begin patients on meclopramide concurrently with the initiation of
enteral tube feeds if the patient has hypoactive bowel sounds. If patients
cannot tolerate tube feeding, then total parenteral nutrition (TPN) is
begun through a central line.
Patients requiring prolonged mechanical
ventilation are also prone for stress gastritis in as much as 40% of the
patients (40). Prophylaxis can be accomplished with fairly equal efficacy
by H2 blockers such as famotidine, proton pump inhibitors such as
lansoprazole, and sucralfate. Among these, sucralfate appears to be
associated with a lessened incidence of nosocomial pneumonia by preserving
the gastric acid barrier between enteric pathogens and the lung (41).
Incidence of nosocomial pneumonia is substantial at 3% per day of
mechanical ventilation (42). Therefore, it is prudent to be vigilant to
its development by noting the quantity and quality of secretions and
monitoring chest x-rays.
Patients on mechanical ventilation are also at
substantial risk for the development of deep venous thrombosis (DVT) in
the legs. This is somewhat less of a concern in post CS patients for the
immediate post operative period, as reports of DVT and PE are rare in this
time frame. This is presumed to be because of the anti-thrombogenic effect
of cardiopulmonary bypass. However, incidence of thromboembolic events
appears to approach that of other patient populations on MV beginning
around fourth postoperative day (18). Our patients typically have support
hose in the immediate post-operative period and, as they get out from CPB,
we will typically use a low molecular weight heparin or pneumatic
compression devices as prophylaxis.
Back
toTop
Click here for Part-2